Digital Medicine Society Accelerates Recruitment and Results With Medrio's eConsent

The Digital Medicine Society (DiMe), an interdisciplinary professional society for digital medicine, was able to deploy Medrio’s eConsent module in less than two weeks to support its remote study to assess nocturnal scratching as an endpoint for patients with atopic dermatitis. The multiphase study is part of an ongoing pre-competitive collaboration with leading pharmaceutical companies, including AbbVie, Janssen, Novartis, Pfizer, and UCB, facilitated by DiMe.

“The aim is to generate reliable scientific evidence that drugmakers, medical device companies, researchers and others can use to develop new digital measurements aiding the research and care for people with eczema,” said DiMe CEO Jennifer Goldsack. “Greater standardization among measures could make it less costly to develop new therapies and get them on the market faster.”